SPRY - ARS Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $22.53. This is a potential upside of $13.42 (147.31%) from yesterday's end of day stock price of $9.11.

ARS Pharmaceuticals's activity chart (see below) currently has 15 price targets and 15 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.75% with an average time for these price targets to be met of 198 days.

Most recent stock forecast was given by JOSH SCHIMMER from CANTOR FITZGERALD on 08-Oct-2024. First documented stock forecast 31-Jan-2023.

Best performing analysts who are covering SPRY - ARS Pharmaceuticals:

Andreas Argyrides Josh Schimmer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$30

$19.95 (198.51%)

$30

1 years 16 days ago
(08-Oct-2024)

0/4 (0%)

$16.12 (116.14%)

Buy

$19

$8.95 (89.05%)

$13

1 years 7 months 13 days ago
(11-Mar-2024)

7/8 (87.5%)

$10.71 (129.19%)

396

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SPRY (ARS Pharmaceuticals) average time for price targets to be met?

On average it took 198 days on average for the stock forecasts to be realized with a an average price target met ratio 43.75

Which analyst has the current highest performing score on SPRY (ARS Pharmaceuticals) with a proven track record?

ANDREAS ARGYRIDES

Which analyst has the current lower performing score on SPRY (ARS Pharmaceuticals) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on SPRY (ARS Pharmaceuticals)?

Andreas Argyrides works at OPPENHEIMER and has 3 price targets and 2 ratings on SPRY

Which analyst is the currently most bullish on SPRY (ARS Pharmaceuticals)?

Josh Schimmer with highest potential upside - $19.95

Which analyst is the currently most reserved on SPRY (ARS Pharmaceuticals)?

Andreas Argyrides with lowest potential downside - $8.95

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?